Registry for Longitudinal Mortality and Therapy in Patients With Heart Failure

Study Overview
=================
Brief Summary
-----------------
The purpose of this registry is to compile a large clinical database on the medical management of patients hospitalized with acute heart failure, using information collected from hospitals across China.

Detailed Description
-----------------
Registry for Longitudinal mortality and therapy in patients with Heart Failure is a large, multicenter, prospective, open-label registry of the management of patients treated in the hospital for acute heart failure in China. The objective of this study is to investigate the clinical features and prognosis of patients with heart failure, and discover the characteristics of high-risk heart failure patients, and elucidate critical factors which predict the development and outcomes of symptomatic heart failure patients. To elucidate the clinical characteristics and prognostic risks of patients with heart failure. To study the characteristics of high-risk heart failure patients and predict the key factors for the development of symptomatic heart failure patients. To elucidate the compliance of patients with heart failure and the incidence of adverse drug effects. To investigate the effect of self-management on outcomes in patients with heart failure. To elucidate critical factors associated with the development and outcomes of heart failure. To investigate hospitalization expenses for heart failure.

Official Title
-----------------
Registry for Longitudinal Mortality and Therapy in Patients With Heart Failure (GREARTWAL Study)

Conditions
-----------------
Heart Failure

Intervention / Treatment
-----------------
* Other: Mortality and Rehospitalization rate


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: - 1. 18 years and older. 2. Meet the diagnostic criteria of China 2018 or JACC/AHA 2017 or ESC 2016 heart failure guidelines. 3. Agree to be tested and sign an informed consent certificate. Exclusion Criteria: 1. Age<18 years old. 2. Patients who refused to participate. 3. Patients may have a life expectancy of less than 1 years due to non- heart failure clinical conditions.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 90 Years

Sexes Eligible for Study
-----------------
All

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Patients with heart failure<br>patients treated in the hospital for acute heart failure in China | Other: Mortality and Rehospitalization rate<br>* Mortality and Re-hospitalization of acute decompensated heart failure<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Mortality of acute decompensated heart failure | In-hospital and Annual mortality | 10 years | 
| Re-hospitalization rate | Re-hospitalization of acute decompensated heart failure | 10 years | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Heart Failure,prognostic, registry